Denial Toxic Encephalopathy due to drugs
We are starting to see an increase in denial on toxic encephalopathy due to drugs. Insurance states that some level of AMS or decreased LOC is integral in cases like polypharmacy or effects of certain drugs. We documentation linkage of toxic encephalopathy due to source. We have GCS scores to help support. Any thoughts or insight maybe missing?
Tagged:
Comments
Sorry if seems a silly question, but it matters in context of topic.
I received a denial recently regarding this. They replaced the G92 code with F19.10 (other psychoactive substance abuse , uncomplicated).
The AHA coding clinic is clear regarding sequencing of toxic encephalopathy if the substance is known.
As long as there is consistent documentation of toxic encephalopathy and the substance/s is/are known, G92 should be coded as a secondary diagnosis.
Any other thoughts on this?